Status:
ACTIVE_NOT_RECRUITING
Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Society of Hospital Medicine
Conditions:
Asthma
Pneumonia
Eligibility:
All Genders
Up to 17 years
Phase:
NA
Brief Summary
This study's objective is to identify and test pragmatic and sustainable strategies for implementing a multi-condition clinical pathway intervention for children hospitalized with asthma, pneumonia, o...
Detailed Description
Asthma, pneumonia, and bronchiolitis are the top causes of childhood hospitalization in the US, leading to approximately 350,000 hospitalizations and $2 billion in costs annually. Poor guideline adopt...
Eligibility Criteria
Inclusion
- Primary diagnosis of asthma AND age \>2 to \<18 years-old at time of admission to the hospital OR
- Primary diagnosis of pneumonia AND age \>2 months and \<18 years at time of admission to the hospital OR
- Primary diagnosis of bronchiolitis AND age \<2 years at time of admission to the hospital
Exclusion
- Diagnosis of SARS-CoV-2
- Transfer in from another inpatient facility
- Pre-existing chronic illnesses (e.g., lung disease, cardiovascular disease, neurologic disorders)
Key Trial Info
Start Date :
May 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
3840 Patients enrolled
Trial Details
Trial ID
NCT05206695
Start Date
May 13 2022
End Date
June 30 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94153